APA (7th ed.) Citation

Berry, J. D., Hagan, M., Zhang, J., Liu, Y., & Ciepielewska, M. Longer disease progression milestone-free time in people with amyotrophic lateral sclerosis treated versus not treated with intravenous edaravone: Results from an administrative claims analysis. Becaris Publishing Limited.

Chicago Style (17th ed.) Citation

Berry, James D., Melissa Hagan, Jeffrey Zhang, Ying Liu, and Malgorzata Ciepielewska. Longer Disease Progression Milestone-free Time in People with Amyotrophic Lateral Sclerosis Treated Versus Not Treated with Intravenous Edaravone: Results from an Administrative Claims Analysis. Becaris Publishing Limited.

MLA (9th ed.) Citation

Berry, James D., et al. Longer Disease Progression Milestone-free Time in People with Amyotrophic Lateral Sclerosis Treated Versus Not Treated with Intravenous Edaravone: Results from an Administrative Claims Analysis. Becaris Publishing Limited.